RMD

#439
ResMed Inc. Common Stock
190.6 3 USD
-7.07%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
190.40
193.42
年范围
2.07
277.67
日变化
-7.07%
每月变动
-10.28%
6个月变化
-20.57%
年变化
-26.40%
前一天收盘价
205.1 4
Open
193.3 5
最低价
190.4 0
High
193.4 2
交易量
1 890
展开完整图表 完整图表

Financials

概览 声明 统计 股息
每季度 年度
  • Market Capitalization 27.65 B
  • Employee 11 K
  • Founded N/A
  • CEO Michael J. Farrell
  • Website www.resmed.com
  • Headquarter Delaware, United States
  • FIGI BBG000L4M7F1
  • Industry 医疗器械及用品
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
21.65
市销率
5.94
每股股息
0.6
股息收益率 %
1.75

ResMed Inc. Common Stock

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024.

新闻